Work

Abstract P233: Sodium Glucose Transporter Type-2 (SGLT-2) Inhibitor, Empagliflozin, Improves Cardiovascular Outcomes in Female Diabetic db/db Mice Independent of Blood Pressure Reduction

Year: 2015

Type: conference-abstract

Source: Hypertension

DOI: 10.1161/hyp.66.suppl_1.p233

Authors: James Sowers, Annayya Aroor, Guanghong Jia, Ravi Nistala, Mona Garro, Gerald Meininger, Luis Martinez-Lemus, Eric Mayoux, Adam Whaley-Connell, Vincent G DeMarco

Institutions: University of Missouri, Boehringer Ingelheim (Germany)

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2340557565

Cites:

Cited by: 2

Related to: 10